VRNA NASDAQ
Verona Pharma plc
1W: +0.3%
1M: +0.6%
3M: +23.1%
1Y: +272.4%
3Y: +1033.7%
5Y: +1517.4%
$106.91
Last traded 2025-10-06 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$474M
+53.9% ▲
5Y CAGR: +51.6%
Total Liabilities
$270M
+358.3% ▲
5Y CAGR: +78.8%
Shareholders Equity
$205M
-17.9% ▼
5Y CAGR: +35.7%
Cash & Investments
$400M
+47.1% ▲
5Y CAGR: +58.2%
Total Debt
$123M
+139.1% ▲
5Y CAGR: +150.4%
Net Debt
-$277M
-25.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $188M | $148M | $228M | $272M | $400M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $188M | $148M | $228M | $272M | $400M |
| Net Receivables | $8M | $16M | $9M | $11M | $37M |
| Inventory | $5M | $4M | $2M | $0 | $6M |
| Other Current Assets | $2M | $2M | $3M | $3M | $3M |
| Total Current Assets | $203M | $170M | $243M | $290M | $454M |
| Property, Plant & Equip. | $1M | $979K | $927K | $3M | $3M |
| Goodwill & Intangibles | $545K | $545K | $545K | $545K | $545K |
| Long-Term Investments | $0 | $15M | $15M | $15M | $15M |
| Other Non-Current Assets | $0 | $15M | $15M | $0 | $2M |
| Total Non-Current Assets | $2M | $17M | $16M | $18M | $21M |
| Total Assets | $204M | $187M | $259M | $308M | $474M |
| — Liabilities — | |||||
| Accounts Payable | $178K | $10M | $3M | $3M | $11M |
| Short-Term Debt | $798K | $0 | $0 | $0 | $1M |
| Deferred Revenue | $11M | $22M | $0 | $0 | $0 |
| Other Current Liabilities | $2M | $327K | $1M | $435K | $2M |
| Total Current Liabilities | $14M | $33M | $19M | $9M | $43M |
| Long-Term Debt | $5M | $5M | $10M | $48M | $120M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $5M | $5M | $10M | $50M | $227M |
| Total Liabilities | $19M | $39M | $29M | $59M | $270M |
| — Equity — | |||||
| Common Stock | $32M | $32M | $41M | $43M | $45M |
| Retained Earnings | -$207M | -$264M | -$333M | -$388M | -$562M |
| Accumulated OCI | -$5M | -$5M | -$5M | -$5M | -$5M |
| Total Stockholders Equity | $185M | $148M | $230M | $249M | $205M |
| Total Liabilities & Equity | $204M | $187M | $259M | $308M | $474M |
| — Key Metrics — | |||||
| Total Debt | $6M | $6M | $11M | $51M | $123M |
| Net Debt | -$182M | -$143M | -$217M | -$220M | -$277M |
| Total Investments | $0 | $15M | $15M | $15M | $15M |